DK0617023T3 - Benzimidazolderivater, deres fremstilling og anvendelse - Google Patents

Benzimidazolderivater, deres fremstilling og anvendelse

Info

Publication number
DK0617023T3
DK0617023T3 DK94610013T DK94610013T DK0617023T3 DK 0617023 T3 DK0617023 T3 DK 0617023T3 DK 94610013 T DK94610013 T DK 94610013T DK 94610013 T DK94610013 T DK 94610013T DK 0617023 T3 DK0617023 T3 DK 0617023T3
Authority
DK
Denmark
Prior art keywords
preparation
benzimidazole derivatives
hydrogen
human
compound
Prior art date
Application number
DK94610013T
Other languages
English (en)
Inventor
Soren-Peter Olesen
Leif Helth Jensen
Peter Moldt
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of DK0617023T3 publication Critical patent/DK0617023T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK94610013T 1993-03-15 1994-03-11 Benzimidazolderivater, deres fremstilling og anvendelse DK0617023T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93288A DK28893D0 (da) 1993-03-15 1993-03-15 Benzimidazole derivater, deres fremstilling og anvendelse

Publications (1)

Publication Number Publication Date
DK0617023T3 true DK0617023T3 (da) 1999-06-28

Family

ID=8091872

Family Applications (2)

Application Number Title Priority Date Filing Date
DK93288A DK28893D0 (da) 1993-03-15 1993-03-15 Benzimidazole derivater, deres fremstilling og anvendelse
DK94610013T DK0617023T3 (da) 1993-03-15 1994-03-11 Benzimidazolderivater, deres fremstilling og anvendelse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK93288A DK28893D0 (da) 1993-03-15 1993-03-15 Benzimidazole derivater, deres fremstilling og anvendelse

Country Status (14)

Country Link
US (1) US5475015A (da)
EP (1) EP0617023B1 (da)
JP (1) JP3748901B2 (da)
KR (1) KR100300800B1 (da)
AT (1) ATE172453T1 (da)
AU (1) AU679023B2 (da)
CA (1) CA2118997C (da)
DE (1) DE69414017T2 (da)
DK (2) DK28893D0 (da)
ES (1) ES2123741T3 (da)
FI (1) FI941214L (da)
NO (1) NO304518B1 (da)
NZ (1) NZ260049A (da)
ZA (1) ZA941816B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
ATE373642T1 (de) * 1999-08-03 2007-10-15 Abbott Lab Kalium kanalaktivatoren
DE10209520A1 (de) * 2002-03-04 2003-09-25 4Sc Ag Neue Modulatoren von Kaliumkanälen
WO2004002962A1 (en) * 2002-06-26 2004-01-08 Poseidon Pharmaceuticals A/S Novel benzimidazol-2-one derivatives and their use
WO2005035498A1 (ja) * 2003-10-08 2005-04-21 Dainippon Sumitomo Pharma Co., Ltd. 含窒素二環性化合物の摂食調節剤としての用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ239540A (en) * 1990-09-24 1993-11-25 Neurosearch As 1-phenyl benzimidazole derivatives and medicaments
US5200422A (en) * 1990-09-24 1993-04-06 Neurosearch A/S Benzimidazole derivatives, their preparation and use

Also Published As

Publication number Publication date
US5475015A (en) 1995-12-12
NO940908D0 (no) 1994-03-14
NZ260049A (en) 1996-03-26
ATE172453T1 (de) 1998-11-15
CA2118997A1 (en) 1994-09-16
EP0617023B1 (en) 1998-10-21
FI941214A7 (fi) 1994-09-16
FI941214L (fi) 1994-09-16
DE69414017D1 (de) 1998-11-26
ES2123741T3 (es) 1999-01-16
ZA941816B (en) 1995-10-13
DK28893D0 (da) 1993-03-15
NO940908L (no) 1994-09-16
AU5649294A (en) 1994-09-22
JP3748901B2 (ja) 2006-02-22
DE69414017T2 (de) 1999-04-08
KR940021534A (ko) 1994-10-19
FI941214A0 (fi) 1994-03-15
EP0617023A1 (en) 1994-09-28
CA2118997C (en) 2002-05-28
JPH06321910A (ja) 1994-11-22
KR100300800B1 (ko) 2001-11-22
AU679023B2 (en) 1997-06-19
NO304518B1 (no) 1999-01-04

Similar Documents

Publication Publication Date Title
DK1137762T3 (da) Behandling af Pompes sygdom
ATE227717T1 (de) 3-pyridylenantiomere und ihre verwendung als analgetika
DK275488D0 (da) Indolonderivater
HU9600834D0 (en) Quinazoline derivatives
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
SE9604786D0 (sv) New compounds
FI870219A0 (fi) Hypoglykemiska tiazolidindioner.
DE69928226T8 (de) Chemokin rezeptor antagonisten und verwendung
DK0477819T3 (da) Benzimidazolderivater, fremstilling og anvendelse heraf
PT920865E (pt) Utilizacao de ""norastemizole"" para o tratamento de disturbios alergicos
NO940908D0 (no) Benzimidazolderivater, deres fremstilling og anvendelse
CY1111900T1 (el) Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα ν-μεθυλ-d-ασπαρτικων (nmda)
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
UA41329C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, похідні 3-фенілсульфоніл-3,7-діазабіцикло[3,3,1]нонану та лікарський засіб для лікування аритмії
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
NO902157L (no) Butensyrederivater for terapeutisk anvendelse.
PT948967E (pt) Tratamento de doencas virais em suicos
BR0213633A (pt) Método e composto para tratar de uma doença associada com recrutamento e/ou ativação aberrante de leucócitos
ATE247903T1 (de) Fungizide zusammensetzung enthaltend ein n- benzoyl-n'-phenyl-harnstoff derivat
DE3884878D1 (de) Uricosuretische Zusammensetzung.
DE69116187D1 (de) Verwendung eines Dihydropyridins zur Verbesserung der Blutzirkulation des inneren Ohres
ATE111462T1 (de) 1,4-dihydropyridin-derivate.
DK0580624T3 (da) Hidtil ukendte cytarabinderivater, fremstilling og anvendelse deraf